Effect of Motivational Interviews on Cardiovascular Disease Risks and Healthy Lifestyle Behavior Changes
The Effect of Motivational Interviews on Cardiovascular Disease Risks and Healthy Lifestyle Behavior Changes in Essential Hypertension Patients: A Randomized Controlled Study
1 other identifier
interventional
80
1 country
1
Brief Summary
The primary aim of this study is to determine the effects of education and motivational interviews structured according to the health belief model on cardiovascular disease risks and healthy lifestyle behavior changes in patients with an essential hypertension diagnosis. The secondary aim of the study is to determine the effects of the variables that mediate the probability of performing primary prevention measures according to the health belief model of patients with a diagnosis of essential hypertension. The study was planned in a single-center, single-blind, one-to-one, parallel-group, randomized controlled trial design with a 6-month follow-up period. The research will be carried out at Işıklar Family Health Center located in Eskişehir city center in Turkey. The study population of this research consists of 659 patients with a diagnosis of essential hypertension, aged between 30-59 years, registered in Işıklar Family Health Center. The number of samples required for the study was determined by the power analysis made in the GPower 3.1 package program. Assuming that there may be losses during the follow-up and considering the possibility of nonparametric testing, a total of 80 individuals, 40 in each group, with an increase of 20%, will form the research group. The research data collection process will be carried out in 4 stages. First of all, the data required to query the inclusion criteria and exclusion criteria for participant admission to the study will be evaluated using the "Data form for participant admission". For the other stages of the research data collection process; "Pre-test (Beginning at 0 months)", "Intermediate follow-up test (Follow-up at 3 months)" and "Posttest (6 months)" will be administered to the participants in the study and control groups by the researcher. In this study, "Cardiovascular Disease Risk Awareness Assessment Scale", "Cardiovascular Diseases Risk Factors Knowledge Level", "Framingham Cardiovascular Risk Score", "Healthy Lifestyle Behaviors Scale-II", "Hypertension Self-Care Profile", "Hill- Bone Hypertension Treatment Adherence Scale", "Physical Activity Questionnaire for Primary Care" and "SF-12 Quality of Life Scale" will be used as data collection tools. In addition to their routine care, the control group will be given a health education structured according to the health belief model and a training booklet on healthy lifestyle behavior changes at the end of the training.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 19, 2022
CompletedFirst Posted
Study publicly available on registry
May 25, 2022
CompletedStudy Start
First participant enrolled
August 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2023
CompletedSeptember 7, 2023
September 1, 2023
3 months
May 19, 2022
September 5, 2023
Conditions
Outcome Measures
Primary Outcomes (5)
Change from Baseline Systolic and Diastolic Blood Pressure at 3 months
Systolic and diastolic blood pressure
3rd month
Change from Baseline Systolic and Diastolic Blood Pressure at 6 months
Systolic and diastolic blood pressure
6th month
Change from Baseline 10-year and 30-year Framingham Cardiovascular Risk Score at 3 months
The risk of developing cardiovascular disease in both the next 10 and 30 years will be calculated using the "Framingham cardiovascular risk score". According to the Framingham cardiovascular risk score, individuals with an estimated 10-year cardiovascular heart disease risk of \<10% are considered low-risk, those between 10% and 20% are considered intermediate-risk, and individuals ≥20% are considered high-risk. The 30-year risk score estimates the 'overall' CVD risk with scores ranging from 0% to 100%. Persons with a 30-year risk score of \< 12% are defined as low risk, between 12% and 40% as intermediate risk, and ≥ 40% as high risk.
3rd month
Change from Baseline 10-year and 30-year Framingham Cardiovascular Risk Score at 6 months
The risk of developing cardiovascular disease in both the next 10 and 30 years will be calculated using the "Framingham cardiovascular risk score". According to the Framingham cardiovascular risk score, individuals with an estimated 10-year cardiovascular heart disease risk of \<10% are considered low-risk, those between 10% and 20% are considered intermediate-risk, and individuals ≥20% are considered high-risk. The 30-year risk score estimates the 'overall' CVD risk with scores ranging from 0% to 100%. Persons with a 30-year risk score of \< 12% are defined as low risk, between 12% and 40% as intermediate risk, and ≥ 40% as high risk.
6th month
Change from Baseline Healthy Lifestyle Behaviors at 6 months
"Healthy Lifestyle Behaviors Scale II" will be used to determine the healthy lifestyle behavior changes of the participants. A minimum of 52 and a maximum of 208 points can be obtained from the scale. Increasing scores from the scale indicate that individuals develop positive healthy lifestyle behaviors.
6th month
Secondary Outcomes (8)
Change from Baseline Cardiovascular Disease Risk Awareness Level at 3 months
3rd month
Change from Baseline Cardiovascular Disease Risk Awareness Level at 6 months
6th month
Change from Baseline Cardiovascular Diseases Risk Factors Knowledge Level at 3 months
3rd month
Change from Baseline Cardiovascular Diseases Risk Factors Knowledge Level at 6 months
6th month
Change from Baseline Motivation Level, Behavior Level and Self-efficacy Level in Hypertension Self-care at 6 months
6th month
- +3 more secondary outcomes
Study Arms (2)
Study group
EXPERIMENTALStudy group intervention consists of 6-session motivational interviews (6 times in total, once every month), a health education structured according to the health belief model, a training booklet on healthy lifestyle behavior changes at the end of the training, and 6-month follow-up.
Control group
OTHERControl group intervention consists of a health education structured according to the health belief model, a training booklet on healthy lifestyle behavior changes at the end of the training, and a 6-month follow-up.
Interventions
A total of 6 motivational interviews will be held once a month. Motivational interviews will be conducted individually.
After the participants enrolled in the study, the patients in the study group will be given a health education structured according to the health belief model at the first interview.
After the participants enrolled in the study and take health education, a training booklet prepared by the researchers on healthy lifestyle behavior changes will be given to the participants.
Follow-ups will be made 3 times in total, on the basis of pre-test, intermediate follow-up test (3 months), and post-test (6 months).
Eligibility Criteria
You may qualify if:
- Volunteer to participate in the research
- Those who are registered with any of the family physicians in the Family Health Center where the research will be conducted.
- Being in the age range of 30-59
- Having a physician-diagnosed essential hypertension
- Having estimated 10-year CHD risk ≥ 10% based on the Framingham risk score
- Being a literate
You may not qualify if:
- Having a disease like coronary artery disease, heart failure, angina, myocardial infarction, cerebrovascular diseases, cancer, or kidney failure.
- Having a pacemaker
- Having a disease like chronic obstructive pulmonary disease, neurological disorder, or psychosis and schizophrenia with severe mental illness
- Has a learning disability or communication disability
- Being pregnant
- Being morbid obese (BMI ≥50 kg/m2)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Işıklar Family Health Center
Eskişehir, Tepebaşı, 26120, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Pınar Duru, PhD
Department of Public Health Nursing, Eskisehir Osmangazi University, Turkey
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- In the study, participants will be left unaware of whether they are in the study or control group (single-blind masking).
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor Doctor
Study Record Dates
First Submitted
May 19, 2022
First Posted
May 25, 2022
Study Start
August 1, 2022
Primary Completion
October 31, 2022
Study Completion
March 31, 2023
Last Updated
September 7, 2023
Record last verified: 2023-09
Data Sharing
- IPD Sharing
- Will not share